Johnny Uy

Person

San Diego, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Modulators of cystic fibrosis transmembrane conductance regulator
- Patent number 12,168,009
- Issue date Dec 17, 2024
- Vertex Pharmaceuticals Incorporated
- Mark Thomas Miller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulators of Cystic Fibrosis Transmembrane Conductance regulator,...
- Patent number 11,866,450
- Issue date Jan 9, 2024
- Vertex Pharmaceuticals Incorporated
- Jeremy J. Clemens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modulator of the cystic fibrosis transmembrane conductance regulato...
- Patent number 11,453,655
- Issue date Sep 27, 2022
- Vertex Pharmaceuticals Incorporated
- Alexander Russell Abela
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modulators of cystic fibrosis transmembrane conductance regulator
- Patent number 11,426,407
- Issue date Aug 30, 2022
- Vertex Pharmaceuticals Incorporated
- Mark Thomas Miller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modulator of cystic fibrosis transmembrane conductance regulator, p...
- Patent number 11,186,566
- Issue date Nov 30, 2021
- Vertex Pharmaceuticals Incorporated
- Timothy Alcacio
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulators of cystic fibrosis transmembrane conductance regulator,...
- Patent number 11,066,417
- Issue date Jul 20, 2021
- Vertex Pharmaceuticals Incorporated
- Jeremy J. Clemens
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulator of the cystic fibrosis transmembrane conductance regulato...
- Patent number 10,793,547
- Issue date Oct 6, 2020
- Vertex Pharmaceuticals Incorporated
- Alexander Russell Abela
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modulators of cystic fibrosis transmembrane conductance regulator
- Patent number 10,758,534
- Issue date Sep 1, 2020
- Vertex Pharmaceuticals Incorporated
- Mark Thomas Miller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulators of cystic fibrosis transmembrane conductance regulator
- Patent number 10,738,030
- Issue date Aug 11, 2020
- Vertex Pharmaceuticals Incorporated
- Brian Bear
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulator of cystic fibrosis transmembrane conductance regulator, p...
- Patent number 10,570,115
- Issue date Feb 25, 2020
- Vertex Pharmaceuticals Incorporated
- Timothy Alcacio
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chroman-spirocyclic piperidine amides as modulators of ion channels
- Patent number 10,385,070
- Issue date Aug 20, 2019
- Vertex Pharmaceuticals Incorporated
- Sara Sabina Hadida-Ruah
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulators of cystic fibrosis transmembrane conductance regulator
- Patent number 10,258,624
- Issue date Apr 16, 2019
- Vertex Pharmaceuticals Incorporated
- Mark Thomas Miller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused piperidine amides as modulators of ion channels
- Patent number 10,233,191
- Issue date Mar 19, 2019
- Vertex Pharmaceuticals Incorporated
- Michael Paul Deninno
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulators of cystic fibrosis transmembrane conductance regulator
- Patent number 9,782,408
- Issue date Oct 10, 2017
- Vertex Pharmaceuticals Incorporated
- Mark Thomas Miller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyran-spirocyclic piperidine amides as modulators of ion channels
- Patent number 9,403,839
- Issue date Aug 2, 2016
- Vertex Pharmaceuticals Incorporated
- Sara Sabina Hadida-Ruah
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzoxazines as modulators of ion channels
- Patent number 9,365,588
- Issue date Jun 14, 2016
- Vertex Pharmaceuticals Incorporated
- Sara Sabina Hadida-Ruah
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quaternary ammonium compounds useful as muscarinic receptor antagon...
- Patent number 9,216,971
- Issue date Dec 22, 2015
- Theravance Biopharma R&D IP, LLC
- Craig Husfeld
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quaternary ammonium compounds useful as muscarinic receptor antagon...
- Patent number 8,815,907
- Issue date Aug 26, 2014
- Theravance Biopharma R&D IP, LLC
- Craig Husfeld
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quaternary ammonium compounds useful as muscarinic receptor antagon...
- Patent number 8,492,407
- Issue date Jul 23, 2013
- Theravance, Inc.
- Craig Husfeld
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quaternary ammonium compounds useful as muscarinic receptor antagon...
- Patent number 8,202,891
- Issue date Jun 19, 2012
- Theravance, Inc.
- Craig Husfeld
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrrolopyridines and pyrazolopyridines as kinase modula...
- Patent number 8,158,647
- Issue date Apr 17, 2012
- SGX Pharmaceuticals, Inc.
- Jeffrey M. Blaney
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator,...
- Publication number 20240368189
- Publication date Nov 7, 2024
- VERTEX PHARMACEUTICALS INCORPORATED
- Jeremy J. Clemens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
- Publication number 20240150377
- Publication date May 9, 2024
- VERTEX PHARMACEUTICALS INCORPORATED
- Jason MCCARTNEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
- Publication number 20230382925
- Publication date Nov 30, 2023
- VERTEX PHARMACEUTICALS INCORPORATED
- Jason MCCARTNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
- Publication number 20230382924
- Publication date Nov 30, 2023
- VERTEX PHARMACEUTICALS INCORPORATED
- Jason MCCARTNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATOR OF THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATO...
- Publication number 20230357191
- Publication date Nov 9, 2023
- Vertex Pharmaceuticals Incorporated
- Alexander Russell Abela
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
- Publication number 20230233560
- Publication date Jul 27, 2023
- VERTEX PHARMACEUTICALS INCORPORATED
- Mark Thomas Miller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATING AGENTS
- Publication number 20220372047
- Publication date Nov 24, 2022
- VERTEX PHARMACEUTICALS INCORPORATED
- Alexander Russell ABELA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
- Publication number 20220313698
- Publication date Oct 6, 2022
- Vertex Pharmaceuticals Incorporated
- Alexander Russell Abela
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODULATOR OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, P...
- Publication number 20220306606
- Publication date Sep 29, 2022
- VERTEX PHARMACEUTICALS INCORPORATED
- Timothy Alcacio
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator,...
- Publication number 20220106331
- Publication date Apr 7, 2022
- VERTEX PHARMACEUTICALS INCORPORATED
- Jeremy J. Clemens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
- Publication number 20210052584
- Publication date Feb 25, 2021
- VERTEX PHARMACEUTICALS INCORPORATED
- Mark Thomas Miller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATOR OF THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATO...
- Publication number 20210047295
- Publication date Feb 18, 2021
- VERTEX PHARMACEUTICALS INCORPORATED
- Alexander Russell Abela
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATOR OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, P...
- Publication number 20200283405
- Publication date Sep 10, 2020
- VERTEX PHARMACEUTICALS INCORPORATED
- Timothy Alcacio
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
- Publication number 20190269683
- Publication date Sep 5, 2019
- VERTEX PHARMACEUTICALS INCORPORATED
- Mark Thomas Miller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator,...
- Publication number 20190248809
- Publication date Aug 15, 2019
- VERTEX PHARMACEUTICALS INCORPORATED
- Jeremy J. Clemens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
- Publication number 20190055220
- Publication date Feb 21, 2019
- VERTEX PHARMACEUTICALS INCORPORATED
- Brian Bear
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
- Publication number 20180185364
- Publication date Jul 5, 2018
- VERTEX PHARMACEUTICALS INCORPORATED
- Mark Thomas Miller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Modulator of the Cystic Fibrosis Transmembrane Conductance Regulato...
- Publication number 20180162839
- Publication date Jun 14, 2018
- VERTEX PHARMACEUTICALS INCORPORATED
- Alexander Russell Abela
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Modulator of Cystic Fibrosis Transmembrane Conductance Regulator, P...
- Publication number 20180093969
- Publication date Apr 5, 2018
- Vertex Pharmaceuticals Incorporated
- Timothy Alcacio
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
- Publication number 20170196862
- Publication date Jul 13, 2017
- VERTEX PHARMACEUTICALS INCORPORATED
- Mark Thomas Miller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Fused Piperidine Amides as Modulators of Ion Channels
- Publication number 20160159815
- Publication date Jun 9, 2016
- VERTEX PHARMACEUTICALS INCORPORATED
- Michael Paul DENINNO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
- Publication number 20160095858
- Publication date Apr 7, 2016
- VERTEX PHARMACEUTICALS INCORPORATED
- Mark Thomas Miller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pyran-Spirocyclic Piperidine Amides as Modulators of Ion Channels
- Publication number 20150005304
- Publication date Jan 1, 2015
- VERTEX PHARMACEUTICALS INCORPORATED
- Sara Sabina Hadida-Ruah
- C07 - ORGANIC CHEMISTRY
Information Patent Application
QUATERNARY AMMONIUM COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGON...
- Publication number 20140329857
- Publication date Nov 6, 2014
- THERAVANCE BIOPHARMA R&D IP, LLC
- Craig Husfeld
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BENZOXAZINES AS MODULATORS OF ION CHANNELS
- Publication number 20140309220
- Publication date Oct 16, 2014
- Sara Sabina Hadida-Ruah
- C07 - ORGANIC CHEMISTRY
Information Patent Application
QUATERNARY AMMONIUM COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGON...
- Publication number 20130281489
- Publication date Oct 24, 2013
- Theravance, Inc.
- Craig Husfeld
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHROMAN-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS
- Publication number 20120245136
- Publication date Sep 27, 2012
- Sara Sabina HADIDA-RUAH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
QUATERNARY AMMONIUM COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGON...
- Publication number 20120232053
- Publication date Sep 13, 2012
- Theravance, Inc.
- Craig Husfeld
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PYRROLOPYRIDINES AND PYRAZOLOPYRIDINES AS KINASE MODULA...
- Publication number 20090005356
- Publication date Jan 1, 2009
- SGX Pharmaceuticals, Inc.
- Jeffrey M. Blaney
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Quaternary ammonium compounds useful as muscarinic receptor antagon...
- Publication number 20080269190
- Publication date Oct 30, 2008
- Theravance, Inc.
- Craig Husfeld
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Modulators of cystic fibrosis transmembrane conductance regulator

Modulators of Cystic Fibrosis Transmembrane Conductance regulator,...

Modulator of the cystic fibrosis transmembrane conductance regulato...

Modulators of cystic fibrosis transmembrane conductance regulator

Modulator of cystic fibrosis transmembrane conductance regulator, p...

Modulators of cystic fibrosis transmembrane conductance regulator,...

Modulator of the cystic fibrosis transmembrane conductance regulato...

Modulators of cystic fibrosis transmembrane conductance regulator

Modulators of cystic fibrosis transmembrane conductance regulator

Modulator of cystic fibrosis transmembrane conductance regulator, p...

Chroman-spirocyclic piperidine amides as modulators of ion channels

Modulators of cystic fibrosis transmembrane conductance regulator

Fused piperidine amides as modulators of ion channels

Modulators of cystic fibrosis transmembrane conductance regulator

Pyran-spirocyclic piperidine amides as modulators of ion channels

Benzoxazines as modulators of ion channels

Quaternary ammonium compounds useful as muscarinic receptor antagon...

Quaternary ammonium compounds useful as muscarinic receptor antagon...

Quaternary ammonium compounds useful as muscarinic receptor antagon...

Quaternary ammonium compounds useful as muscarinic receptor antagon...

Substituted pyrrolopyridines and pyrazolopyridines as kinase modula...

Patents Applicationslast 30 patents

Modulators of Cystic Fibrosis Transmembrane Conductance Regulator,...

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

MODULATOR OF THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATO...

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATING AGENTS

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

MODULATOR OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, P...

Modulators of Cystic Fibrosis Transmembrane Conductance Regulator,...

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

MODULATOR OF THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATO...

MODULATOR OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, P...

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

Modulators of Cystic Fibrosis Transmembrane Conductance Regulator,...

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

Modulator of the Cystic Fibrosis Transmembrane Conductance Regulato...

Modulator of Cystic Fibrosis Transmembrane Conductance Regulator, P...

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

Fused Piperidine Amides as Modulators of Ion Channels

Modulators of Cystic Fibrosis Transmembrane Conductance Regulator

Pyran-Spirocyclic Piperidine Amides as Modulators of Ion Channels

QUATERNARY AMMONIUM COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGON...

BENZOXAZINES AS MODULATORS OF ION CHANNELS

QUATERNARY AMMONIUM COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGON...

CHROMAN-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS

QUATERNARY AMMONIUM COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGON...

SUBSTITUTED PYRROLOPYRIDINES AND PYRAZOLOPYRIDINES AS KINASE MODULA...

Quaternary ammonium compounds useful as muscarinic receptor antagon...